All In Biotech

Drug Trial Radar · NCT00705341

MethaCholine Bronchoprovocation Study (MeCIS)

MethaCholine Bronchoprovocation - Influence of High Potency Inhaled corticoSteroids in Asthma (MeCIS) Study

Last checked: Nov 20, 2026Latest source record: Feb 12, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 219 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

219

Actual

Start

Jan 2009

Primary completion

Feb 2010

Study completion Feb 2010

Sponsor

Lead sponsor
Johns Hopkins Bloomberg School of Public HealthAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Washington University School of Medicine; St. Louis University; Long Island Jewish Medical Center; North Shore University Hospital; Baylor College of Medicine; University of Vermont; Nemours Children's Clinic; University of Florida; Indiana University; Ohio State University; NYU Langone Health; University of Missouri-Columbia; Northwestern University; Louisiana State University Health Sciences Center in New Orleans; University of Miami; University of South Florida; University of California, San Diego; National Jewish Health; Duke University
First posted
Jun 26, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Crossover
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Diagnostic
Who can join
All sexes, from 12 years, up to 69 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this research is to evaluate the methacholine challenge test as an accurate indicator of asthma in patients receiving treatment for asthma. Phase 1 on the study compares methacholine challenge test results from asthma patients to those from people who do not have asthma. In phase 2, test results for people with asthma on low dose inhaled corticosteroid will be compared to results on high dose inhaled corticosteroids. Both males and females with stable asthma (asthma participants) and without asthma (controls) enrolled. Participants will be between 12 and 69 years of age.

Conditions

  • Asthma

Interventions

  • fluticasoneDrug

    Inhaled corticosteroid approved for treatment of asthma

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Methacholine Challenge Test Result for Phase 2Time frame: weeks 0, 4

Locations

13 sites in 1 country. Site status is shown where the registry gives one.

  • University of California at San Diego

    San Diego, California

  • The Nemours Children's Clinic

    Jacksonville, Florida

  • University of Miami/Univestiy of South Florida

    Miami, Florida

  • Northwestern University Memorial Hospital

    Chicago, Illinois

  • Indiana University

    Indianapolis, Indiana

  • Louisianna State University

    New Orleans, Louisiana

  • University of Missouri-Kansas City

    Kansas City, Missouri

  • Washington University School of Medicine

    St Louis, Missouri

  • Long Island Jewish Medical Center

    New Hyde Park, New York

  • New York Consortium/Columbia University

    New York, New York

  • New York Medical College

    Valhalla, New York

  • Ohio State University

    Columbus, Ohio

  • Vermont Lung Center at the University of Vermont

    Burlington, Vermont

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.